Vertical Peak Holdings Inc (SPLIF)
0.004
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Vertical Peak Holdings Total Assets (Quarterly): 9.155M for April 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
April 30, 2023 | 9.155M |
January 31, 2023 | 8.938M |
October 31, 2022 | 9.080M |
July 31, 2022 | 9.740M |
April 30, 2022 | 15.44M |
January 31, 2022 | 17.80M |
October 31, 2021 | 18.40M |
July 31, 2021 | 5.834M |
April 30, 2021 | 7.908M |
January 31, 2021 | 7.822M |
October 31, 2020 | 8.831M |
July 31, 2020 | 4.980M |
April 30, 2020 | 10.43M |
January 31, 2020 | 12.73M |
October 31, 2019 | 16.21M |
July 31, 2019 | 14.81M |
April 30, 2019 | 19.40M |
January 31, 2019 | 26.62M |
October 31, 2018 | 25.42M |
July 31, 2018 | 20.92M |
April 30, 2018 | 14.97M |
January 31, 2018 | 6.921M |
October 31, 2017 | 5.250M |
July 31, 2017 | 6.524M |
Date | Value |
---|---|
April 30, 2017 | 7.256M |
January 31, 2017 | 7.422M |
October 31, 2016 | 3.476M |
July 31, 2016 | 2.042M |
April 30, 2016 | 2.601M |
January 31, 2016 | 1.858M |
October 31, 2015 | 1.522M |
July 31, 2015 | 1.516M |
April 30, 2015 | 1.529M |
January 31, 2015 | 0.9058M |
October 31, 2014 | 0.547M |
April 30, 2014 | |
January 31, 2014 | |
October 31, 2013 | |
July 31, 2013 | 0.00 |
April 30, 2013 | 0.00 |
January 31, 2013 | 0.00 |
July 31, 2012 | 0.00 |
July 31, 2010 | 0.0045M |
April 30, 2010 | 0.0104M |
January 31, 2010 | 0.0038M |
October 31, 2009 | 0.0038M |
July 31, 2009 | 0.0076M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.980M
Minimum
Jul 2020
19.40M
Maximum
Apr 2019
11.62M
Average
9.740M
Median
Jul 2022
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 7.832M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 16.64M |
Shareholders Equity (Quarterly) | -7.331M |
Debt to Equity Ratio | -1.072 |
Current Ratio | 0.2192 |
Net Debt Paydown Yield | 14.01% |